March 9, 2023

Press release - Regulatory

Targovax ASA – First Tranche of Convertible Bonds

March 9, 2023

Press release - Regulatory

Targovax ASA: Minutes from the Extraordinary General Meeting

March 7, 2023

Press release - Regulatory

Targovax to prioritize resources on unlocking the potential of its circRNA platform

March 6, 2023

Press release - Regulatory

Targovax ASA – Additional information prior to the Extraordinary General Meeting

March 6, 2023

Press release - Regulatory

Targovax ASA: Registration of share capital increase following settlement of restricted stock units

March 2, 2023

Press release - Regulatory

Targovax ASA: Mandatory notification of trade by primary insiders pertaining to RSUs

March 2, 2023

Press release - Regulatory

Targovax ASA: Settlement of restricted stock units and resolution to increase the share capital

March 1, 2023

Press release - Regulatory

Targovax ASA – Additional information prior to the Extraordinary General Meeting

February 23, 2023

Press release - Regulatory

Targovax invites to Q&A webcast regarding convertible bond financing

February 16, 2023

Press release - Regulatory

Targovax ASA – Notice of Extraordinary General Meeting

February 16, 2023

Press release - Regulatory

Targovax ASA: Fourth quarter 2022 results

February 16, 2023

Press release - Regulatory

Targovax announces financing of up to NOK 300m over three years to advance its clinical cancer programs & pre-clinical circular RNA platform

February 8, 2023

Press release - Regulatory

Targovax ASA: Invitation to Targovax’s fourth quarter 2022 presentation, Thursday 16 February